MedPath

Dasetta 7/7/7

DASETTATM 7/7/7 (norethindrone/ethinyl estradiol Tablets, USP)

Approved
Approval ID

da52e74a-1baf-4a33-a068-b49176700320

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 26, 2018

Manufacturers
FDA

Northstar Rx LLC

DUNS: 830546433

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

norethindrone and ethinyl estradiol

PRODUCT DETAILS

NDC Product Code16714-346
Application NumberANDA090946
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateDecember 15, 2017
Generic Namenorethindrone and ethinyl estradiol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dasetta 7/7/7 - FDA Drug Approval Details